TWST
NASD Twist Bioscience Corp.$135.00 ↑ +2.25 (+1.69%) Trading Up from the previous close of $132.75
- YTD change
- +325.60%
- vs 20-day SMA
- -19.63%
- vs 200-day SMA
- +62.15%
Price ranges
Price & Performance
+70.87 (+114.53%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 38.6% away from all-time highs of $219.71
- TWST is up 326% since the beginning of the year
- TWST is up 379% over the past 12 months
- TWST is down 19% over the past 1 month
- 17% of all TWST investors are betting against TWST
TWST reads not so good: price sits above one of the two key moving averages, the 12-month move is +305.5%.
- Previous minute
- +$1.59
- Last hour
- +$0.97
- Last 5 days
- -15.51%
- vs 8-day SMA
- -9.70%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
